Liquid Urine Control Level 3 For Professional Use in the quality control monitoring of In-Vitro Diagnostic Urinary Clinical Assays on a range of clinical chemistry systems.
Published June 7, 2017 · Recall initiated: April 27, 2017
Summary
FDA records medical device Class III recall Z-2167-2017, published June 7, 2017 and initiated April 27, 2017. Recalling firm: Randox Laboratories; Status: Terminated; Reported quantity: 198 kits; Lot: Catalogue number UC5075 Batch number 907UC. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
According to Randox Laboratories an investigation indicates a labelling error for 2 of the test methods listed for quantification of Total Protein (urine). The values for the mean of all instruments are incorrect by a factor of 10. Instrument specific values are correct. This does not affect the performance or stability claims of the product. As control results will be outside of the quoted range this may result in a delay in reporting the sample test results. However as the correct instrument specific means are also included in the value sheet this delay is unlikely. Customers have been referred to their Medical Director for further advice
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Randox Laboratories
- Distributor
- Worldwide Distribution - US Distribution to Puerto Rico and to the countries of : Canada Kuwait Chile Poland China Romania France Saudi Arabia Guatemala Slovenia Iran UAE India UK Italy Uruguay Iraq
- Lot
- Catalogue number UC5075 Batch number 907UC
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDARX Imola (RX4900) For Professional Use for the quantitative in vitro determination of various clinicalJune 13, 2018
- FDAPausch Uroview FD fluoroscopic X-ray system UDI number (01)04260491620040 Primarily for urologicalJune 7, 2017
- FDAAIA-PACK TPOAb CONTROL SETJune 7, 2017
- FDAThe Green Herb 100% Natural AL-ER-G, 60 and 150 Capsules, Dietary supplement, This item is packed in a whiteJune 7, 2017
- FDA1000 ml Canister (with Gel) for InfoV.A.C. and V.A.C.ULTA Therapy Systems (Part Number M8275093/5). TheJune 7, 2017
- FDAQueso Hondureno, Queso Duro Blando - Honduran Cheese, Dry Hard Cheese; 1 lb 454 gJune 7, 2017
Questions about this recall
Was Liquid Urine Control Level 3 For Professional Use in the quality control monitoring of In-Vitro Diagnostic Urinary Clinical Assays on a range of clinical chemistry systems. recalled?
Yes. FDA published recall Z-2167-2017 on June 7, 2017. Reported hazard: According to Randox Laboratories an investigation indicates a labelling error for 2 of the test methods listed for quantification of Total Protein (urine). The values for the mean of all instruments are incorrect by a factor of 10. Instrument specific values are correct. This does not affect the performance or stability claims of the product. As control results will be outside of the quoted range this may result in a delay in reporting the sample test results. However as the correct instrument specific means are also included in the value sheet this delay is unlikely. Customers have been referred to their Medical Director for further advice
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail